Tokyo, Japan

Daisuke Fukuoka


 

Average Co-Inventor Count = 3.0

ph-index = 1


Location History:

  • Haga-gun, JP (2013)
  • Tokyo, JP (2019)

Company Filing History:


Years Active: 2013-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Daisuke Fukuoka: Innovator in Antibody and Hyperglycemia Research

Introduction

Daisuke Fukuoka is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies and agents for managing blood glucose levels. With a total of 2 patents, Fukuoka's work is recognized for its potential impact on health and medicine.

Latest Patents

Fukuoka's latest patents include an anti-active GIP antibody and a postprandial hyperglycemia-improving agent. The anti-active GIP antibody is designed to allow accurate detection of active GIP. This invention provides an antibody that binds specifically to active GIP while avoiding nonactive GIP. The antibody recognizes specific amino acids within the sequence represented by SEQ ID NO: 5, including a critical region in the H chain.

The postprandial hyperglycemia-improving agent is another notable invention. This agent is characterized by its high safety profile and effectiveness in inhibiting postprandial increases in blood glucose levels. It comprises cycloartenol or its derivatives as the active ingredient, showcasing Fukuoka's commitment to developing safe and effective health solutions.

Career Highlights

Daisuke Fukuoka is currently associated with Kao Corporation, a leading company in the consumer goods and chemical industry. His work at Kao Corporation has allowed him to focus on innovative research that bridges the gap between biotechnology and practical health applications.

Collaborations

Fukuoka collaborates with esteemed colleagues such as Akira Shimotoyodome and Noriko Osaki. Their combined expertise enhances the research and development efforts within their projects.

Conclusion

Daisuke Fukuoka's contributions to biotechnology through his patents reflect his dedication to improving health outcomes. His innovative work in antibody development and blood glucose management positions him as a key figure in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…